We randomly assigned 11,140 patients with type 2 diabetes to undergo either standard glucose control or intensive glucose control, defined as the use of gliclazide (modified release) plus other drugs ...

Intensive glucose control doesn't reduce mortality risk in critically ill patients when compared with conventional glucose control. Instead, it increases the risk for severe hypoglycemia by threefold, ...

Strategy reduced nephropathy risky by 21% in patients with type 2 diabetes, study finds. Intensive glucose control with gliclazide (modified release) and other agents reduced the risk of nephropathy ...

The researchers said their analysis is the most comprehensive yet to explore how intensive blood pressure control affects people’s health. Intensive efforts to bring down high blood pressure can lower ...

(HealthDay News) — During long-term follow-up, the impact of a 4-year period of intensive glycemic control has a neutral effect on death and nonfatal cardiovascular events, according to a study ...

A new study published in *The Lancet* last week noted that for people diagnosed with high blood pressure, intensive blood pressure control (defined as using medication and lifestyle changes to lower a ...

WINSTON-SALEM, N.C. – Jan. 21, 2025 – A new study from researchers at Wake Forest University School of Medicine shows that only 3½ years of intensive blood pressure control continues to significantly ...

Whether intensive systolic blood-pressure control or standard control is better for cardiovascular risk reduction in patients with type 2 diabetes has been unclear. New research findings are ...

The belief that the lower the glucose level the better in patients with type 2 diabetes who are at a high risk for MI or stroke has been called into question by an ongoing NIH-supported trial.

Intensive blood pressure control has no effect on the progression of hypertensive chronic kidney disease in black patients, a randomised controlled trial has shown. US researchers randomly assigned ...